Literature DB >> 6193374

VIL-A1, a monoclonal antibody reactive with common acute lymphatic leukemia cells.

W Knapp, O Majdic, P Bettelheim, K Liszka.   

Abstract

The VIL-A1 monoclonal antibody raised against Reh cells reacts with common acute lymphatic leukemia (CALL) cells but not with normal or malignant B or T lymphocytes. It also shows no binding to normal or malignant myeloid, monocytic or erythroid cells, nor does it react with thrombocytes. The antibody is of IgM class and lyses CALL cells very efficiently in the presence of rabbit but not human complement. Immunoprecipitation experiments followed by SDS-polyacrylamide gel electrophoresis under reducing conditions revealed that VIL-A1 defines a 95,000 mol. wt membrane protein. Approximately 40% of it binds to lens culinaris lectin. Capping experiments showed that the membrane component defined by VIL-A1 co-caps with the one recognized by another recently described monoclonal antibody to CALL cells (J5).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6193374     DOI: 10.1016/0145-2126(82)90019-4

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  18 in total

1.  Lineage-related polypeptide markers in acute lymphoblastic leukemia detected by two-dimensional gel electrophoresis.

Authors:  S M Hanash; L J Baier; L McCurry; S A Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

2.  Influence of pre-incubation with one antibody on the binding of a second by human lymphocytes.

Authors:  F Eichler-Reiss; P Reizenstein; G Mathé
Journal:  Med Oncol Tumor Pharmacother       Date:  1985

3.  Immature sinus histiocytes. Their identification as a novel B-cell population.

Authors:  H Stein; K Lennert; D Y Mason; S Liangru; A Ziegler
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

4.  Monoclonal antibodies against differentiation antigens of lymphopoiesis.

Authors:  E Thiel
Journal:  Blut       Date:  1983-11

5.  Cross-reactivity between human hemopoietic cells and brain tumors as defined by monoclonal antibodies.

Authors:  H Budka; O Majdic; W Knapp
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

6.  Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.

Authors:  R Foa; N Migone; M Saitta; M T Fierro; M C Giubellino; P Lusso; L Cordero di Montezemolo; R Miniero; F Lauria
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

7.  Use of monoclonal antibodies as a diagnostic tool in human leukemia. I. Acute myeloid leukemia and acute phase of chronic myeloid leukemia.

Authors:  F Herrmann; B Komischke; E Odenwald; W D Ludwig
Journal:  Blut       Date:  1983-09

8.  Characterization of early lymphoid precursor cells in the human fetus using monoclonal antibodies and anti-terminal deoxynucleotidyl transferase.

Authors:  G E Asma; R L van den Bergh; J M Vossen
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

9.  Shared antigenic determinants between human hemopoietic cells and nervous tissues and tumors.

Authors:  H Budka; O Majdic
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

10.  Heterogeneity of T-cell neoplasias as defined by monoclonal antibodies.

Authors:  F Herrmann; B Komischke; G Sieber; H Rühl
Journal:  Klin Wochenschr       Date:  1983-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.